Skip to main content
SpringerLink
Log in

Percutaneous Management of Valvular Heart Disease

  • Chapter
  • First Online:
Book cover Device Therapy in Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 876 Accesses

Abstract

Heart failure afflicts nearly five million Americans, with a large proportion of patients over the age 65. While ischemic heart disease accounts for most cases, 6–9% of all cases of heart failure may be attributed to valvular heart disease. This chapter describes the percutaneous therapies available to treat valvular heart disease and includes both a review of available clinical data and a discussion of past and current device technologies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007–18.

    Article  PubMed  Google Scholar 

  2. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation 2000;102:1076–8.

    CAS  PubMed  Google Scholar 

  3. Rankin JS, Hammill BG, Ferguson TB, Jr., et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006;131:547–57.

    Article  PubMed  Google Scholar 

  4. Chen CR, Cheng TO, Huang T, et al. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults. N Engl J Med 1996;335:21–5.

    Article  CAS  PubMed  Google Scholar 

  5. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 2008;52:e1–142.

    Article  PubMed  Google Scholar 

  6. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 2000;102:813–6.

    CAS  PubMed  Google Scholar 

  7. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403–5.

    Article  CAS  PubMed  Google Scholar 

  8. Coats L, Tsang V, Khambadkone S, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg 2005;27:536–43.

    Article  PubMed  Google Scholar 

  9. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation 2002;106:1703–7.

    Article  PubMed  Google Scholar 

  10. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189–97.

    Article  PubMed  Google Scholar 

  11. Boudjemline Y, Pineau E, Borenstein N, Behr L, Bonhoeffer P. New insights in minimally invasive valve replacement: description of a cooperative approach for the off-pump replacement of mitral valves. Eur Heart J 2005;26:2013–7.

    Article  PubMed  Google Scholar 

  12. Boudjemline Y, Laborde F, Pineau E, et al. Expandable right ventricular-to-pulmonary artery conduit: an animal study. Pediatr Res 2006;59:773–7.

    Article  PubMed  Google Scholar 

  13. Boudjemline Y, Schievano S, Bonnet C, et al. Off-pump replacement of the pulmonary valve in large right ventricular outflow tracts: a hybrid approach. J Thorac Cardiovasc Surg 2005;129:831–7.

    Article  PubMed  Google Scholar 

  14. Boudjemline Y, Agnoletti G, Bonnet D, Sidi D, Bonhoeffer P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract: an experimental study. J Am Coll Cardiol 2004;43:1082–7.

    Article  PubMed  Google Scholar 

  15. Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv 2006;67:659–62.

    Article  PubMed  Google Scholar 

  16. Carabello BA, Crawford FA, Jr. Valvular heart disease. N Engl J Med 1997;337:32–41.

    Article  CAS  PubMed  Google Scholar 

  17. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465–9.

    Article  PubMed  Google Scholar 

  18. Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 2006;113:1738–44.

    Article  PubMed  Google Scholar 

  19. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704–8.

    CAS  PubMed  Google Scholar 

  20. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–8.

    Article  PubMed  Google Scholar 

  21. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003;348:1756–63.

    Article  CAS  PubMed  Google Scholar 

  22. Zile MR, Gaasch WH. Heart failure in aortic stenosis – improving diagnosis and treatment. N Engl J Med 2003;348:1735–6.

    Article  PubMed  Google Scholar 

  23. Brown ML, Schaff HV, Sarano ME, Li Z, Sundt TM, Dearani JA, Mullany CH, Orszulak TA. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg 2008;136:566–71.

    Article  PubMed  Google Scholar 

  24. Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation 2004;109:1572–9.

    Article  PubMed  Google Scholar 

  25. American Heart Association. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991;84:2383–97.

    Google Scholar 

  26. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89: 642–50.

    CAS  PubMed  Google Scholar 

  27. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522–8.

    Article  CAS  PubMed  Google Scholar 

  28. Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005;95:43–7.

    Article  PubMed  Google Scholar 

  29. Pavcnik D, Wright KC, Wallace S. Development and initial experimental evaluation of a prosthetic aortic valve for transcatheter placement. Work in progress. Radiology 1992;183:151–4.

    CAS  PubMed  Google Scholar 

  30. Cribier A, Eltchaninoff H, Borenstein N et al. Trans-catheter implantation of balloon-expandable prosthetic heart valves: early results in an animal model. Circulation 2001;104:II-552.

    Google Scholar 

  31. Bauer F, Eltchaninoff H, Tron C, et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 2004;110:1473–6.

    Article  PubMed  Google Scholar 

  32. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698–703.

    Article  PubMed  Google Scholar 

  33. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842–50.

    Article  PubMed  Google Scholar 

  34. Leon MB. Interventions in Structural Heart Disease: My Expectations for the Disease: My Expectations for the Next 5–10 years. Catheter Interventions in Congenital Catheter Interventions in Congenital & Structural Heart Disease & Structural Heart Disease 9th International Workshop Frankfurt, Germany 2006.

    Google Scholar 

  35. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591–6.

    Article  PubMed  Google Scholar 

  36. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116:I240–5.

    Article  PubMed  Google Scholar 

  37. Feldman T, Herrmann HC, Inoue K. Technique of percutaneous transvenous mitral commissurotomy using the Inoue balloon catheter. Cathet Cardiovasc Diagn 1994;Suppl 2:26–34.

    CAS  PubMed  Google Scholar 

  38. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299–308.

    Article  CAS  PubMed  Google Scholar 

  39. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465–71.

    Article  PubMed  Google Scholar 

  40. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331:961–7.

    Article  CAS  PubMed  Google Scholar 

  41. Patel JJ, Shama D, Mitha AS, et al. Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study. J Am Coll Cardiol 1991;18:1318–22.

    Article  CAS  PubMed  Google Scholar 

  42. Turi ZG, Reyes VP, Raju BS, et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. A prospective, randomized trial. Circulation 1991;83:1179–85.

    CAS  PubMed  Google Scholar 

  43. Maisano F, Schreuder JJ, Oppizzi M, Fiorani B, Fino C, Alfieri O. The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg 2000;17:201–5.

    Article  CAS  PubMed  Google Scholar 

  44. Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998;13:240–5; discussion 245–6.

    Article  CAS  PubMed  Google Scholar 

  45. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022–8.

    CAS  PubMed  Google Scholar 

  46. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916–24.

    PubMed  Google Scholar 

  47. Otto CM. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001;345:740–6.

    Article  CAS  PubMed  Google Scholar 

  48. Otto CM, Salerno CT. Timing of surgery in asymptomatic mitral regurgitation. N Engl J Med 2005;352:928–9.

    Article  CAS  PubMed  Google Scholar 

  49. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759–64.

    CAS  PubMed  Google Scholar 

  50. Kaji S, Nasu M, Yamamuro A, et al. Annular geometry in patients with chronic ischemic mitral regurgitation: three-dimensional magnetic resonance imaging study. Circulation 2005;112:I409–14.

    PubMed  Google Scholar 

  51. Watanabe N, Ogasawara Y, Yamaura Y, et al. Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study. Circulation 2005;112:I458–62.

    Article  PubMed  Google Scholar 

  52. Messas E, Guerrero JL, Handschumacher MD, et al. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation 2001;104:1952–7.

    Article  CAS  PubMed  Google Scholar 

  53. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001;104:1958–63.

    Article  CAS  PubMed  Google Scholar 

  54. Fucci C, Sandrelli L, Pardini A, Torracca L, Ferrari M, Alfieri O. Improved results with mitral valve repair using new surgical techniques. Eur J Cardiothorac Surg 1995;9:621–6; discussion 626–7.

    Article  CAS  PubMed  Google Scholar 

  55. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134–40.

    Article  PubMed  Google Scholar 

  56. Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation 2006;113:851–5.

    Article  PubMed  Google Scholar 

  57. Liddicoat JR, Mac Neill BD, Gillinov AM, et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 2003;60:410–6.

    Article  PubMed  Google Scholar 

  58. Daimon M, Shiota T, Gillinov AM, et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation 2005;111:2183–9.

    Article  PubMed  Google Scholar 

  59. Virmani R, Chun PK, Parker J, McAllister HA, Jr. Suture obliteration of the circumflex coronary artery in three patients undergoing mitral valve operation. Role of left dominant or codominant coronary artery. J Thorac Cardiovasc Surg 1982;84:773–8.

    CAS  PubMed  Google Scholar 

  60. Wykrzykowska J, Cohen D, Zimetabum P. Mitral annuloplasty causing left circumflex injury and infarction: novel use of intravascular ultrasound to diagnose suture injury. J Invasive Cardiol 2006;18:505–8.

    PubMed  Google Scholar 

  61. Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation 2006;114:377–80.

    Article  PubMed  Google Scholar 

  62. Rogers JH, Macoviak JA, Rahdert DA, Takeda PA, Palacios IF, Low RI. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation 2006;113:2329–34.

    Article  PubMed  Google Scholar 

  63. Boudjemline Y, Agnoletti G, Bonnet D, et al. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J Am Coll Cardiol 2005;46:360–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Joanna J. Wykrzykowska MD

  2. Cardiology Division, St. Elizabeth Medical Center, Brighton, MA, USA

    Joseph P. Carrozza Jr MD (Chief)

Authors
  1. Joanna J. Wykrzykowska MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph P. Carrozza Jr MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Pilgrim Road 185, Boston, 02215, U.S.A.

    William H. Maisel

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wykrzykowska, J.J., Carrozza, J.P. (2010). Percutaneous Management of Valvular Heart Disease. In: Maisel, W. (eds) Device Therapy in Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-424-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-424-7_12

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-994-9

  • Online ISBN: 978-1-59745-424-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation